JPRN-C000000035已完成未知
A Randomized Phase III trial of chemotherapy alone versus chemotherapy followed by gefitinib in stage IIIB/IV non-small cell lung cancer - A Randomized Phase III trial of chemotherapy alone versus chemotherapy followed by gefitinib in stage IIIB/IV non-small cell lung cancer
West Japan Thoracic Oncology Group (WJTOG)0 个研究点目标入组 600 人开始时间: 2005年9月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •Pregnancy or breast feeding Past history of drug hypersensitivity SVC syndrome Pleural or pericardial effusion that required drainage Active infection Interstitial pneumonia or active lung fibrosis Symptomatic brain metastasis Active concomitant malignancy Uncontrolled diabetes Uncontrolled heart disease
研究者
相似试验
进行中(未招募)
不适用
A Phase 3 Randomized Trial of Chemotherapy With or Without Panitumumab in Patients with Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck - NDMetastatic and/or Recurrent Squamous Cell Carcinoma of the Head and NeckMedDRA version: 6.1Level: HLTClassification code 10024530EUCTR2006-003786-13-ITAMGEN S.P.A.650
进行中(未招募)
1 期
A Phase 3 Randomized Trial of Chemotherapy With or Without Panitumumab in Patients with Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and NeckMetastatic and/or Recurrent Squamous Cell Carcinoma of the Head and NeckMedDRA version: 9.1Level: LLTClassification code 10060121Term: Squamous cell carcinoma of head and neckEUCTR2006-003786-13-FRAmgen Inc650
进行中(未招募)
不适用
A Phase 3 Randomized Trial of Chemotherapy With or Without Panitumumab in Patients with Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and NeckMetastatic and/or Recurrent Squamous Cell Carcinoma of the Head and NeckMedDRA version: 9.1Level: LLTClassification code 10060121Term: Squamous cell carcinoma of head and neckEUCTR2006-003786-13-DEAmgen Inc.650
进行中(未招募)
不适用
A Phase 3 Randomized Trial of Chemotherapy With or Without Panitumumab in Patients with Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and NeckMetastatic and/or Recurrent Squamous Cell Carcinoma of the Head and NeckMedDRA version: 9.1Level: LLTClassification code 10060121Term: Squamous cell carcinoma of head and neckEUCTR2006-003786-13-HUAmgen Inc650
进行中(未招募)
不适用
A Phase 3 Randomized Trial of Chemotherapy With or Without Panitumumab in Patients with Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and NeckMetastatic and/or Recurrent Squamous Cell Carcinoma of the Head and NeckMedDRA version: 9.1Level: LLTClassification code 10060121Term: Squamous cell carcinoma of head and neckEUCTR2006-003786-13-PTAmgen Inc650
